Evaluation of the Graves’ Orbitopathy-Specific Quality of Life Questionnaire in the Mainland Chinese Population
Table 3
Results of the univariate analysis of Grave’s ophthalmopathy patients.
Covariate
Visual functioning
Appearance
Sex
0.015
0.123
Female
73.5 ± 30.9
58.3 ± 28.7
Male
58.4 ± 29.3
68.9 ± 24.6
Age
0.214
0.800
13–24 y
77.5 ± 21.7
57.9 ± 27.1
25–54 y
70.4 ± 29.7
63.3 ± 25.6
55–73 y
56.2 ± 36.9
61.3 ± 31.4
Diplopia
<0.001
0.696
No diplopia
81.2 ± 22.7
63.7 ± 24.8
Diplopia
50.8 ± 32.7
59.5 ± 30.4
Proptosis
0.546
0.261
≤20 mm
68.2 ± 29.9
63.6 ± 28.1
>20 mm
68.9 ± 34.5
57.3 ± 24.4
Clinical activity
0.003
0.001
Inactive
71.8 ± 30.2
65.5 ± 26.3
Active
41.9 ± 25.6
34.0 ± 17.5
Severity
0.002a
0.407
Mild
84.1 ± 18.2
66.6 ± 24.8
Moderate-severe
65.2 ± 31.1
62.4 ± 26.2
Sight-threatening
51.6 ± 35.3
54.5 ± 31.0
Wilcoxon rank-sum test or Kruskal–Wallis rank-sum test. aSeverity: mild versus moderate-to-severe, ; mild versus sight-threatening, ; and moderate-to-severe versus sight-threatening, (least significant difference adjusted: α = 0.05/3 = 0.0167).
